MENU
+Compare
BYSI
Stock ticker: NASDAQ
AS OF
Apr 11 closing price
Price
$1.10
Change
+$0.01 (+0.92%)
Capitalization
43.94M

BYSI BeyondSpring Forecast, Technical & Fundamental Analysis

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies... Show more

BYSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BYSI with price predictions
Apr 11, 2025

Momentum Indicator for BYSI turns negative, indicating new downward trend

BYSI saw its Momentum Indicator move below the 0 level on March 21, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned negative. In of the 80 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for BYSI turned negative on March 19, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

BYSI moved below its 50-day moving average on March 19, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BYSI crossed bearishly below the 50-day moving average on March 10, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BYSI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BYSI entered a downward trend on April 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BYSI advanced for three days, in of 241 cases, the price rose further within the following month. The odds of a continued upward trend are .

BYSI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (13.293). P/E Ratio (0.000) is within average values for comparable stocks, (62.876). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.750). Dividend Yield (0.000) settles around the average of (0.026) among similar stocks. P/S Ratio (31.056) is also within normal values, averaging (244.810).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BYSI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BYSI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
BYSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BYSI is expected to report earnings to rise 29.31% to -75 cents per share on July 10

BeyondSpring BYSI Stock Earnings Reports
Q1'23
Est.
$-0.75
Q4'22
Missed
by $0.30
Q3'22
Missed
by $0.21
Q2'22
Missed
by $0.13
Q1'22
Est.
$-0.23
The last earnings report on April 18 showed earnings per share of -57 cents, missing the estimate of -28 cents. With 80.88K shares outstanding, the current market capitalization sits at 43.94M.
A.I. Advisor
published General Information

General Information

a manufacturer of cancer therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
28 Liberty Street
Phone
+1 646 305-6387
Employees
67
Web
https://www.beyondspringpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WKEY4.230.88
+26.27%
WISeKey International Holding Ltd
BTBT1.850.12
+6.94%
Bit Digital
FCX33.352.00
+6.38%
Freeport-McMoran
TGTX36.710.73
+2.03%
TG Therapeutics
LADR9.86-0.13
-1.30%
LADDER CAPITAL Corp

BYSI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BYSI has been loosely correlated with GOSS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if BYSI jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BYSI
1D Price
Change %
BYSI100%
+0.92%
GOSS - BYSI
38%
Loosely correlated
+6.18%
CYTK - BYSI
37%
Loosely correlated
+2.11%
VNDA - BYSI
33%
Poorly correlated
+1.23%
APGE - BYSI
32%
Poorly correlated
N/A
RCUS - BYSI
31%
Poorly correlated
+9.07%
More